1. Home
  2. NTRA vs EIX Comparison

NTRA vs EIX Comparison

Compare NTRA & EIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRA
  • EIX
  • Stock Information
  • Founded
  • NTRA 2003
  • EIX 1886
  • Country
  • NTRA United States
  • EIX United States
  • Employees
  • NTRA N/A
  • EIX N/A
  • Industry
  • NTRA Medical Specialities
  • EIX Electric Utilities: Central
  • Sector
  • NTRA Health Care
  • EIX Utilities
  • Exchange
  • NTRA Nasdaq
  • EIX Nasdaq
  • Market Cap
  • NTRA 18.4B
  • EIX 19.6B
  • IPO Year
  • NTRA 2015
  • EIX N/A
  • Fundamental
  • Price
  • NTRA $141.08
  • EIX $54.99
  • Analyst Decision
  • NTRA Strong Buy
  • EIX Buy
  • Analyst Count
  • NTRA 17
  • EIX 14
  • Target Price
  • NTRA $184.65
  • EIX $76.19
  • AVG Volume (30 Days)
  • NTRA 1.5M
  • EIX 3.7M
  • Earning Date
  • NTRA 08-07-2025
  • EIX 07-31-2025
  • Dividend Yield
  • NTRA N/A
  • EIX 6.03%
  • EPS Growth
  • NTRA N/A
  • EIX 172.85
  • EPS
  • NTRA N/A
  • EIX 6.80
  • Revenue
  • NTRA $1,831,000,000.00
  • EIX $17,539,000,000.00
  • Revenue This Year
  • NTRA $19.98
  • EIX $8.17
  • Revenue Next Year
  • NTRA $16.16
  • EIX $2.88
  • P/E Ratio
  • NTRA N/A
  • EIX $8.08
  • Revenue Growth
  • NTRA 51.50
  • EIX 4.26
  • 52 Week Low
  • NTRA $100.22
  • EIX $47.73
  • 52 Week High
  • NTRA $183.00
  • EIX $88.77
  • Technical
  • Relative Strength Index (RSI)
  • NTRA 44.33
  • EIX 63.54
  • Support Level
  • NTRA $131.81
  • EIX $51.01
  • Resistance Level
  • NTRA $141.45
  • EIX $56.03
  • Average True Range (ATR)
  • NTRA 4.85
  • EIX 1.35
  • MACD
  • NTRA 0.67
  • EIX 0.42
  • Stochastic Oscillator
  • NTRA 76.04
  • EIX 79.88

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About EIX Edison International

Edison International is the parent company of Southern California Edison, an electric utility that distributes electricity to 5 million customers in a 50,000-square-mile area of Southern California, excluding Los Angeles. Edison Energy owns interests in nonutility businesses that deal in energy-related products and services. In 2014, Edison International sold its wholesale power generation subsidiary Edison Mission Energy out of bankruptcy to NRG Energy.

Share on Social Networks: